You are using an older browser version. Please use a supported version for the best MSN experience.

T. Rowe Price Health Sciences

PRHSX
62.93
+0.46
+0.74%
5/25/2016
5 Years
  • Previous Close

    62.47

  • Net Assets

    11.80B

  • Yield

    0.00%

  • Front load

    None

  • Expenses

    0.76%

  • Category

    Health

  • Morningstar Risk

    Above Average

  • Morningstar Rating ★★★★★
Profile

Name of Issuer

T. Rowe Price

Fund Style

Open

Fund Manager

Taymour Tamaddon

Investment Style

Large Growth

The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

Purchase Information

Initial Purchase 2,500
Initial Purchase: IRA 1,000
Initial Purchase: AIP 2,500

Inception

12/29/1995

AdChoices
AdChoices
AdChoices
image beaconimage beaconimage beacon